ONT
NEUTRALOxford Nanopore Grants LTIP and DBP Awards to Directors
The healthcare technology company has granted long-term incentive plan (LTIP) and deferred bonus plan (DBP) awards to its directors.
Oxf Nanopore Technologies
120.50GBX
2.21%
Market Cap
1.15B
Volume
2.5k
0% of avg
P/E Ratio
-0.08
EPS (TTM)
-14.43
Beta
0.9
Day Range
0.00p - 0.00p
52 Week Range
0.00p120.50p169.20p
120.50p
Upcoming Events
2027
Target year for adjusted EBITDA breakeven
High Impact Event
2028
Target year for becoming cash flow positive
High Impact Event
ONT
NEUTRALOxford Nanopore Technologies Announces Director Share Purchases
The biotechnology company has announced that a director has purchased shares under the firm's employee share plan.
ONT
NEUTRALOxford Nanopore Announces Shareholder Update
The prominent biotechnology company has released a shareholder update, providing details on its ownership structure.
ONT
NEUTRALOxford Nanopore and Cepheid partner on automated sequencing solutions
The biotechnology company has announced a strategic collaboration with Cepheid to develop and commercialise a workflow for sequencing-based infectious disease analysis.
ONT
NEUTRALOxford Nanopore Director Purchases Shares
The director of this major biotechnology company has purchased a number of shares in the company.
ONT
NEUTRALOxford Nanopore Technologies Announces PDMR Share Purchases
The biotechnology company has announced a PDMR's purchase of shares under its employee share plan.
ONT
NEUTRALOxford Nanopore Announces Director Share Incentive Plan Award
The biotechnology company has announced a director's participation in its employee share scheme, with no material impact on the business.
ONT
NEUTRALOxford Nanopore Director Purchases Shares
The biotechnology company announces a director has purchased 77,000 shares in the business.
ONT
NEUTRALOxford Nanopore Announces Change in Major Shareholding
The biotechnology company has announced a change in major shareholding, with EIT Oxford Holdings, LLC increasing its stake to over 11%.
ONT
NEUTRALOxford Nanopore Announces Change in Major Shareholding
The biotechnology company has announced a change in major shareholding, with EIT Oxford Holdings, LLC increasing its stake to 10.947% of the voting rights.